APA (7th ed.) Citation

MR, G., MB, G., M, D., E, M., M, T., H, R., . . . A, K. (2026). Safety and Efficacy of Once-Daily Oral Paltusotine in Acromegaly: ACROBAT Advance Open-Label Extension Up to 4 Years. The Journal of clinical endocrinology and metabolism. https://doi.org/10.1210/clinem/dgag254

Chicago Style (17th ed.) Citation

MR, Gadelha, et al. "Safety and Efficacy of Once-Daily Oral Paltusotine in Acromegaly: ACROBAT Advance Open-Label Extension Up to 4 Years." The Journal of Clinical Endocrinology and Metabolism 2026. https://doi.org/10.1210/clinem/dgag254.

MLA (9th ed.) Citation

MR, Gadelha, et al. "Safety and Efficacy of Once-Daily Oral Paltusotine in Acromegaly: ACROBAT Advance Open-Label Extension Up to 4 Years." The Journal of Clinical Endocrinology and Metabolism, 2026, https://doi.org/10.1210/clinem/dgag254.